Выпуск
Pharmaceutical Executive Daily: FDA Approves Expanded Indication for Camzyos
Pharmaceutical Executive · 1 октября 2026 г. · 2 мин
Regeneron and Sanofi expand their antibody alliance with four new drug candidates, FDA approves Camzyos for adolescents with obstructive hypertrophic cardiomyopathy, and Michael Abrams questions digital health's savings claims to employers.